4174 |
北城證券研發部提供 非經同意不得轉載 本刊內容僅供參考 投資人應謹慎考量投資風險 本公司不負任何法律責任 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4174 浩鼎 |
實收資本額 |
2632 (百萬) |
|
|
|
|
|
|
|
|
|
市 場
別 |
OTC |
上 櫃 日 期 |
2015/03/23 |
|
|
|
|
|
|
|
|
|
發 言
人 |
王慧君 |
電 話 |
(02)2655-8799 |
|
|
|
|
|
|
|
|
|
地 址 |
(115011)台北市南港區忠孝東路7段508號6樓 |
|
|
|
|
|
|
|
|
|
產 業
別 |
傳產-生技 |
|
|
|
|
|
|
|
|
|
主要產品 |
新藥研發 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025/5/2 股價 |
39.75 |
法人買賣超合計(近一日) |
買超 148 張 |
|
|
|
|
|
|
|
|
|
2025/5/2
漲跌 |
0.35
|
法人買賣超合計(近一週) |
買超
1551.68 張 |
|
|
|
|
|
|
|
|
|
2025/5/2
漲跌幅 |
0.89
|
法人買賣超合計(近一月) |
買超
1147.6 張 |
|
|
|
|
|
|
|
|
|
券 資 比 |
0.92
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
最新股利發放 |
股東會日期 |
現金股利(元) |
股票股利(元) |
除權日 |
除息日 |
殖利率 |
|
|
|
|
|
|
|
2023/06/27 |
#N/A |
#N/A |
#N/A |
#N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
股利年度 |
股東會日期 |
現金股利(元) |
股票股利(元) |
除權日 |
除息日 |
扣抵率(%) |
殖利率 |
股利殖利率 |
現金殖利率 |
|
|
|
|
2024 |
2025/06/27 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
2023 |
2024/06/17 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
2022 |
2023/06/27 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
2021 |
2022/06/27 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
機構估稅後EPS |
-8.06 |
K(9) |
29.07 |
|
技術面 |
技術面 |
基本面 |
基本面 |
籌碼面 |
|
|
|
|
淨值(元) |
14.51 |
D(9) |
21.63 |
評分表 |
(短線) |
(中長線) |
(安全性) |
(成長性) |
|
|
|
|
預估本益比 |
-4.93 |
周K(9) |
20.27 |
|
1.6 |
0.8 |
0.8 |
2 |
0.5 |
|
|
|
|
股價淨值比 |
2.74 |
周D(9) |
32.69 |
綜合評分: |
5.7 |
建議: |
列入追踪 |
目標價: |
52.89 |
|
|
|
|
月線乖離率 |
-14.15 |
季線乖離率 |
-27.99 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025/4/2 |
2025/4/11 |
2025/4/18 |
2025/4/25 |
2025/5/2 |
20*PE |
|
3*PB |
51.62 |
|
|
|
|
股價 |
62.00 |
46.90 |
47.00 |
38.00 |
39.75 |
15*PE |
|
2*PB |
34.42 |
|
|
|
|
成交量(千股) |
2,113 |
7,294 |
3,230 |
3,313 |
20,056 |
10*PE |
|
1*PB |
17.21 |
|
|
|
|
資餘 |
4,090 |
3,676 |
3,738 |
3,437 |
3,786 |
5*PE |
|
0.5*PB |
8.60 |
|
|
|
|
券餘 |
15 |
7 |
0 |
203 |
35 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
季IFRS財報(損益單季) |
202501 |
202404 |
202403 |
202402 |
202401 |
202304 |
202303 |
202302 |
|
|
|
|
營業收入淨額(千) |
|
11,548
|
22,979
|
19,016
|
9,135
|
18,419
|
11,476
|
9,868
|
|
|
|
|
營業成本(千) |
|
32,655
|
38,058
|
32,937
|
35,302
|
32,628
|
32,936
|
28,468
|
|
|
|
|
營業毛利(千) |
|
-21,107 |
-15,079 |
-13,921 |
-26,167 |
-14,209 |
-21,460 |
-18,600 |
|
|
|
|
營業費用(千) |
|
700,625
|
518,978
|
531,264
|
544,387
|
472,534
|
596,535
|
534,272
|
|
|
|
|
營業利益(千) |
|
-721,732 |
-534,057 |
-545,185 |
-570,554 |
-486,743 |
-617,995 |
-552,872 |
|
|
|
|
營業外收入及支出(千) |
|
-42,782 |
-45,644 |
-41,398 |
5,144
|
-76,381 |
-8,903 |
889,877
|
|
|
|
|
稅前純益(千) |
|
-764,514 |
-579,701 |
-586,583 |
-565,410 |
-563,124 |
-626,898 |
337,005
|
|
|
|
|
所得稅(千) |
|
10,099
|
-17,906 |
2,500
|
1,745
|
2,787
|
-13,383 |
1,734
|
|
|
|
|
稅後純益(千) |
|
-774,613 |
-561,795 |
-589,083 |
-567,155 |
-565,911 |
-613,515 |
335,271
|
|
|
|
|
其他綜合損益(千) |
|
-334 |
-1,695 |
3,680
|
1,152
|
-2,222 |
1,235
|
3,490
|
|
|
|
|
綜合損益(千) |
|
-774,947 |
-563,490 |
-585,403 |
-566,003 |
-568,133 |
-612,280 |
338,761
|
|
|
|
|
原始每股稅前盈餘(元) |
|
-2.91 |
-2.53 |
-2.56 |
-2.47 |
-2.46 |
-2.73 |
1.47
|
|
|
|
|
原始每股稅後盈餘(元) |
|
-2.77 |
-2.27 |
-2.36 |
-2.28 |
-2.29 |
-2.48 |
1.78
|
|
|
|
|
毛利率(%) |
|
-182.78 |
-65.62 |
-73.21 |
-286.45 |
-77.14 |
-187.00 |
-188.49 |
|
|
|
|
營業利益率(%) |
|
-6,249.84 |
-2,324.11 |
-2,866.98 |
-6,245.80 |
-2,642.61 |
-5,385.11 |
-5,602.68 |
|
|
|
|
稅後純益率(%) |
|
-6,707.77 |
-2,444.82 |
-3,097.83 |
-6,208.59 |
-3,072.43 |
-5,346.07 |
3,397.56
|
|
|
|
|
稅後權益報酬率(%) |
|
-18.82 |
-15.25 |
-14.09 |
-12.12 |
-10.82 |
-10.59 |
5.37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
月營收 |
單月營收(千) |
累計營收(千) |
單月MoM |
單月YoY |
累計YoY |
累計稅前EPS |
備註 |
近3月營收(千) |
近3月年成長 |
|
|
|
|
202504 |
0 |
0 |
0.00
|
0.00
|
0.00
|
|
|
0 |
0 |
|
|
|
|
202503 |
2,924 |
14,458 |
-73.37 |
-9.45 |
58.27
|
|
|
14,458
|
58.27 |
|
|
|
|
202502 |
10,979 |
11,534 |
1878.20
|
145.23
|
95.29
|
|
|
19,376
|
48.76 |
|
|
|
|
202501 |
555 |
555 |
-92.92 |
-61.16 |
-61.16 |
|
創近一年新低 |
10,350
|
-31.36 |
|
|
|
|
202412 |
7,842 |
62,678 |
301.54
|
10.16
|
50.85
|
-9.48 |
|
11,548
|
-37.3 |
|
|
|
|
202411 |
1,953 |
54,836 |
11.41
|
-70.10 |
59.27
|
|
|
8,366
|
-49.8 |
|
|
|
|
202410 |
1,753 |
52,883 |
-62.38 |
-63.24 |
89.55
|
|
|
12,358
|
-5.69 |
|
|
|
|
202409 |
4,660 |
51,130 |
-21.61 |
-13.12 |
121.05
|
-6.58 |
|
22,979
|
100.24 |
|
|
|
|
202408 |
5,945 |
46,470 |
-51.96 |
100.17
|
161.57
|
|
|
26,369
|
87.4 |
|
|
|
|
202407 |
12,374 |
40,525 |
53.71
|
293.83
|
173.89
|
|
創近一年新高 |
27,108
|
110.12 |
|
|
|
|
202406 |
8,050 |
28,151 |
20.44
|
1.14
|
141.56
|
-4.38 |
創近一年新高 |
19,016
|
92.7 |
|
|
|
|
202405 |
6,684 |
20,101 |
56.10
|
271.33
|
444.01
|
|
|
14,195
|
297.95 |
|
|
|
|
202404 |
4,282 |
13,417 |
32.61
|
3828.44
|
608.02
|
|
|
11,988
|
551.88 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
券商代號 |
券商名稱 |
張增減 |
買張 |
賣張 |
券商代號 |
券商名稱 |
張增減 |
買張 |
賣張 |
|
|
|
|
8440 |
摩根大通 |
119 |
154 |
35 |
5850 |
統一 |
-172 |
60 |
232 |
|
|
|
|
8880 |
國泰 |
112 |
237 |
125 |
1480 |
美商高盛 |
-75 |
22 |
97 |
|
|
|
|
9200 |
凱基 |
95 |
274 |
179 |
9300 |
華南永昌 |
-61 |
70 |
131 |
|
|
|
|
1470 |
台灣摩根士丹利 |
61 |
90 |
29 |
8840 |
玉山 |
-47 |
58 |
105 |
|
|
|
|
9800 |
元大 |
47 |
406 |
359 |
9600 |
富邦 |
-38 |
271 |
309 |
|
|
|
|
1650 |
新加坡商瑞銀 |
31 |
97 |
66 |
1560 |
港商野村 |
-36 |
2 |
38 |
|
|
|
|
6160 |
中國信託 |
26 |
35 |
9 |
7000 |
兆豐 |
-25 |
62 |
87 |
|
|
|
|
9A00 |
永豐金 |
22 |
106 |
84 |
1030 |
土銀 |
-14 |
6 |
20 |
|
|
|
|
6910 |
德信 |
10 |
10 |
0 |
5960 |
日茂 |
-13 |
5 |
18 |
|
|
|
|
5380 |
第一金 |
6 |
14 |
8 |
6110 |
台中銀 |
-10 |
10 |
20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20250501 |
浩鼎抗癌藥 獲美核准臨床 |
|
|
|
|
20250424 |
浩鼎抗乳癌新藥開發喊卡 股價重挫、6,000張跌停賣單高掛 |
|
|
|
|
20250331 |
台股大地震 法人逾連十天大買這些股撿漏 |
|
|
|
|
20250123 |
浩鼎新型肉毒桿菌素 報捷 |
|
|
|
|
20250110 |
潤泰全營收/12月為4.1億元 年增120.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
個股TOP15買賣超券商籌碼統計(20日) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1日籌碼集中度 |
-2.4 |
|
10日籌碼集中度 |
-2.9 |
|
單日買賣超 |
-57 |
|
|
|
5日籌碼集中度 |
-3.3 |
|
20日籌碼集中度 |
-3.4 |
|
累計買賣超 |
-2976 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
個股借券統計(20日) |
千張大戶統計(20週) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
單日借賣張數 |
6973 |
借券餘額 |
7868 |
千張大戶戶數 |
30 |
大戶比例 |
43.39 |
|
|
|
|
|
|
|
|
|
|
|
|
更新日期: |
2025/5/2 17:48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|